Search results for: 'funding pipeline'

This research service analyzes Japan's FY 2024 national defense budget request and the Defense Buildup Program (FY 2023 FY 2027) to briefly discuss Japan's indigenous defense manufacturing prowess and growth outlook. The study examines Japan's national policies, international defense, and security relationships, and the regional geopolitical climat...

The infectious disease IVD market in Indonesian presents diversified growth potential for different tiers of participants. Domestic participants stand to gain from the growth momentum in the lower-end market, whereas foreign leading manufacturers dominate the higher-end market. This research service analyses the infectious disease IVD market and p...

The Chinese pharmaceutical market is expected to be the third-largest in the world in 2013. This research service analyzes various aspects of the Chinese pharmaceutical market between 2007 and 2016. Rising income, improving healthcare infrastructure, and insurance systems are some factors that drive this market. The study discusses in detail the ma...

This report explores the market for smart water meter solutions in the Asia-Pacific (APAC). APAC is currently experiencing significant water stress due to climate change and rapid urbanization, driving water utilities in the region to increasingly adopt smart water meters as a strategy to reduce water consumption and minimize non-revenue water loss...

16 Dec 2020  |  Asia Pacific  |  Market Research

SoftBank Mobility Strategies, 2030

With $268 Billion in Equity and a $100 Billion Vision Fund, the Conglomerate will Leverage AI to Become a Powerhouse of the Automotive and Connected Living Environment

Infographics

×

SoftBank, with its $100 billion Vision Fund, has created the biggest investment cycle in history and has given start-ups a head start to launch their technology. Investments are focused on futuristic technologies such as artificial intelligence (AI), the Internet of Things, and mobile applications across various sectors. AI will play an important r...

With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...

More than 6,000 molecules are currently in clinical development across the pharmaceutical research and development (R&D) landscape, with more than 11,000 in the preclinical phase. The industry is witnessing the growth of small- to mid-segment pharma/biotech players making significant contributions to drug discovery and development pipelines. Across...

This Frost Radar™ examines the Asia-Pacific customer experience (CX) management services landscape, which is a subset of the broader business process outsourcing/management industry. Usually, CX management is a business arrangement in which a company contracts an outside supplier to perform a service rather than accomplishing it in-house. Services ...

This Frost Radar™ examines the Australian customer experience (CX) management services landscape, which is a subset of the broader business process outsourcing/management industry. In a CX management arrangement, a company contracts an outside supplier to run customer service work instead of doing it in-house. The work ranges from handling simple c...